Different expression patterns of beta-defensins in human squamous cell carcinomas

Area of Science:

• Oral pathology
• Immunology
• Molecular biology

Background:

• Human beta-defensins (HBDs) are antimicrobial peptides with known roles in innate immunity.
• Oral squamous cell carcinoma (OSCC) is a prevalent malignancy with complex pathogenesis.
• The specific roles of HBDs in OSCC development remain incompletely understood.

Purpose of the Study:

• To investigate the expression patterns of human beta-defensin-2 (HBD-2) and human beta-defensin-3 (HBD-3) in oral squamous cell carcinomas (OSCCs).
• To explore the potential involvement of HBD-2 and HBD-3 in the tumor microenvironment of OSCCs.

Main Methods:

• In situ hybridization was employed to detect the expression of HBD-2 and HBD-3 genes.
• Expression levels were quantified and analyzed in tumor tissues and adjacent normal oral epithelia from 20 OSCC patients.

Main Results:

• HBD-2 expression was detected in 15 out of 20 OSCCs, including non-inflamed areas, and also in normal epithelia adjacent to tumors.
• HBD-3 expression was observed in only 4 out of 20 OSCCs.
• HBD-2 expression was noted in inflamed lesions with bacterial infection, but also significantly in non-inflamed carcinomas.

Conclusions:

• HBD-2 expression in OSCCs suggests a role distinct from its typical defensive function.
• HBD-2 may contribute to OSCC progression by inducing apoptosis in adjacent normal keratinocytes, potentially facilitating tumor cell proliferation.
• Further research is warranted to elucidate the precise mechanisms of HBD-2 in oral cancer development.